A further hypothesis is that ME/CFS could include misdirected immune responses to the initial infection, resulting in a chronic autoimmune disease with molecular mimicry (the hit and run hypothesis) (85)
de Haan JB, Bladier C, Griffiths P, Kelner M, OShea RD, Cheung NS, Bronson RT, Silvestro MJ, Wild S, Zheng SS, et al
247 Additionally, there is a lack of uniform labeling standards, with many products omitting details about exact dosages, plant parts used, extraction solvents, or potential herb-drug interactions
typical muscle loss with weight loss) Greater improvements in insulin sensitivity and lipid profiles Immune Optimization (Thymosin Alpha-1) Target Patient Profile: Chronic viral infections (EBV, Lyme, long COVID) Recurrent infections suggesting immune deficiency Cancer patients during or post-treatment Autoimmune conditions requiring immune modulation Recovery from severe illness or major surgery Treatment Protocol: Baseline: Complete immune panel including lymphocyte subsets (CD4, CD8, NK cells), inflammatory markers Dosing: 1.6 mg subcutaneously 2-3 times weekly for chronic support
